• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tumor Microenvironment: Tumor Infiltrating Lymphocyte Score Predicts Breast Cancer Outcome

  • — 27 Mar, 2015

VIENNA—Because harnessing the immune system is now proven as a way of managing breast cancer, clinicians should consider the role of tumor infiltrating lymphocytes, according to Giuseppe Curigliano MD PhD, Director of the Early Drug Development for Innovative Therapies Division at the European Institute of Oncology, Milan—who presented an update of their role in mediating immune pathways in cancer at the St Gallen Breast Cancer Conference. He gave Oncology Times reporter Sarah Maxwell his insights into how the “immunome” could be used as a target.

You may also like...

  • Adjuvant Chemoradiotherapy: Big Gains In Pancreas Cancer Adjuvant Chemoradiotherapy: Big Gains In Pancreas Cancer 27 Jan, 2008
  • Oliver Gautschi MD Growing Evidence that Anti BRAF Melanoma Drugs Benefit Some Patients with Non-Small Cell Lung Cancer 27 Apr, 2015
  • PSA-membrane antibody conjugate shows promise for treating metastatic castration-resistant, taxane-refractory prostate cancer PSA-membrane antibody conjugate shows promise for treating metastatic castration-resistant, taxane-refractory prostate cancer 6 Feb, 2014
  • PD-L1 Checkpoint Inhibitor Immunotherapy Boosts Survival in Lung Cancer PD-L1 Checkpoint Inhibitor Immunotherapy Boosts Survival in Lung Cancer 6 Dec, 2016
  • Previous story International Research and Consensus Needed to Interpret Breast Cancer Genomics Data
  • Next story BCL-2: A New Therapeutic Target in Estrogen-Receptor Positive Breast Cancer
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After Allogeneic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Which Tasks Most Influence Pediatric PT Productivity,…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
  • Home
  • Oncology
  • Tumor Microenvironment: Tumor Infiltrating Lymphocyte Score Predicts Breast Cancer Outcome

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.